The Lower Eastern Times Opening The Third Eye
Related Articles
The Pharmacy and Poisons Board has issued a recall for two batches of Efinox nasal drops following a labeling mix-up that could make the products unsafe for use.
The affected batches, Batch No. 82979 (Efinox 1% w/v) and Batch No. 82978 (Efinox 0.5% w/v), were manufactured by Laboratory and Allied Ltd, Kenya.
In a statement released on Friday, the Board explained that the error in labeling and packaging led to a discrepancy in the strength of the two products, which poses potential health risks. The Board has called on pharmacies, healthcare facilities, and the public to immediately stop the distribution, sale, and use of the affected batches.
“The Pharmacy and Poisons Board has mandated the recall of Efinox 1% w/v Batch No. 82979 and Efinox 0.5% w/v Batch No. 82978, manufactured by Laboratory and Allied Ltd, Kenya,” the statement read.
Efinox is commonly used as a nasal drop to relieve congestion, but due to the labeling mix-up, the strength of the medicine in these batches does not correspond to the indicated dosage, raising concerns about safety.
The Board has also advised that any remaining stock of the affected batches be returned to the nearest health facility or to the respective suppliers. In addition, members of the public have been urged to report any adverse reactions or side effects from the use of the affected product batches, and to be vigilant for counterfeit drugs.
Consumers and healthcare providers can also connect with the Pharmacy and Poisons Board via WhatsApp for further inquiries.
For more information on how to safely return the affected product, or to report concerns, the Board encourages people to reach out to the relevant authorities or visit local pharmacies.
